Abbott India stock falls 1.13 percent below its 200 day line

Published on 09/22/2026 at 10:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Abbott India stock traded at INR 26,964.10 on September 22, 2026, down 1.13 percent from the prior close. June 2026 revenue reached INR 1,889.05 crore.

Abbott India, INE358A01014, Illustration mit AI erstellt.

Abbott India stock (ISIN INE358A01014) traded at INR 26,964.10 on the NSE on September 22, 2026, down 1.13 percent from the prior close of INR 27,273.30. The same session recorded an intraday range of INR 26,851.85 to INR 27,300.00, placing the price below the 200 day line at INR 26,965.50.

Stock tests a key chart level

The latest market setup is technical rather than event-driven. Abbott India traded between INR 25,140.50 and INR 30,670.45 over the 52-week period reported on September 22, 2026, so the current price stood INR 3,706.40 above the low and INR 3,706.35 below the high. That symmetry puts the share almost exactly midway through its reported annual range.

The technical reading adds a measurable counterpoint to the long-term record. Year to date through September 22, 2026, the stock was down 7.24 percent, while its three-year return was positive at 18.04 percent. The contrast shows why the current chart level matters: short-term performance is weak, but the longer historical comparison remains positive.

June revenue and profit increased

Abbott India reported revenue of INR 1,889.05 crore for the quarter ended June 30, 2026, compared with INR 1,811.19 crore in the June 2025 quarter, an increase of 4.29 percent. EBITDA rose from INR 518.43 crore to INR 597.87 crore over the same period, while net income increased from INR 365.86 crore to INR 428.52 crore.

Quarterly EPS reached INR 201.66 in June 2026, versus INR 172.17 in June 2025. The 17.13 percent EPS increase was faster than revenue growth, indicating that operating leverage and cost development were more important to the earnings comparison than topline expansion alone.

Market value and operating scale

Abbott India had a market capitalization of INR 57,946.85 crore as of September 18, 2026, according to the available market overview. Trading volume was 6,596 shares on that date, against a one-month daily average of 7,643 shares, while the price-to-earnings ratio was 33.67 based on trailing earnings through June 2026.

The company operates in health care and pharmaceuticals and is listed on the NSE under the ticker ABBOTINDIA. Its reported financial table shows fiscal-year 2026 revenue of INR 7,295.05 crore, EBITDA of INR 2,259.66 crore and net income of INR 1,614.68 crore, with the June 2026 quarter providing the latest explicitly identified interim period.

Price remains below the yearly high

At INR 26,964.10 on the NSE on September 22, 2026, Abbott India stock was 12.09 percent below the reported 52-week high of INR 30,670.45 and 7.25 percent above the reported low of INR 25,140.50. The combination of a 1.13 percent daily decline, a position below the 200 day line and faster June EPS growth defines the current investor debate.